SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: g.w. barnard who wrote (3284)12/10/1997 3:48:00 PM
From: Steve Childs  Read Replies (2) of 23519
 
Vivus failed to provide any of the requested
information. Asensio & Company believes Vivus' 25% sales drop is a result of
poor product performance and early nonrecurring sales to undisclosed sources.

Oh how nice. This is what I fear most: poor reorder rates. Script data provided by Bond showed a 31% renewal rate. Isn't that low in this business?

If there is a shed of truth in Asensio's analysis (even though they are known short-sellers), VVUS is history.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News